| Pharmaceutical Information |
| Drug Name |
Phenylpropanolamine |
| Drug ID |
BADD_D01764 |
| Description |
Phenylpropanolamine is a sympathomimetic agent that acts as a nonselective adrenergic receptor agonist and norepinephrine reuptake inhibitor. It has been used as a decongestant and appetite suppressant. Currently, it is withdrawn from the market in Canada and the United States due to the risk for hemorrahgic strokes. |
| Indications and Usage |
For the treatment of nasal congestion, control of urinary incontinence, priapism and obesity. |
| Marketing Status |
approved; vet_approved; withdrawn |
| ATC Code |
R01BA01 |
| DrugBank ID |
DB00397
|
| KEGG ID |
D08368
|
| MeSH ID |
D010665
|
| PubChem ID |
4786
|
| TTD Drug ID |
D09JXM
|
| NDC Product Code |
63083-1534 |
| UNII |
33RU150WUN
|
| Synonyms |
Phenylpropanolamine | Norephedrine | Propagest | Phenylpropanolamine Hydrochloride | Hydrochloride, Phenylpropanolamine | Prolamine | Triaminic DM | Dexatrim |
|
| Chemical Information |
| Molecular Formula |
C9H13NO |
| CAS Registry Number |
14838-15-4 |
| SMILES |
CC(C(C1=CC=CC=C1)O)N |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
